학술논문

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Document Type
Article
Source
In The Lancet 4-10 November 2017 390(10107):2073-2082
Subject
Primary Research
Articles
Language
ISSN
0140-6736